Commission Implementing Regulation (EU) 2018/155 of 31 January 2018 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances (Text with EEA relevance. )

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC ¹, and in particular Article 19, thereof,

Whereas:

• (1) Commission Implementing Regulation (EU) No 686/2012 ² allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluation of active substances whose approval expires between 1 January 2022 and 31 December 2024 has not yet been allocated to a Member State or to a co-rapporteur Member State, it is appropriate to proceed to such allocation.

• (2) In view of the length of the evaluation process for active substances and the recent notification by the United Kingdom pursuant to Article 50 of the Treaty on European Union ³, it is necessary to re-allocate the evaluation of the active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 for which the United Kingdom is the rapporteur Member State or the co-rapporteur Member State, and for which no supplementary dossier has yet been submitted. The active substances concerned are aluminium ammonium sulphate, azoxystrobin, bupirimate, carbetamide, chlormequat, ethylene, fenbuconazole, fluopicolide, fluquinconazole, flutriafol, garlic extract, metazachlor, myclobutanil, paclobutrazol, pepper, plant oils/citronella oil, propaquizafop, quizalofop-p-ethyl, quizalofop-p-tefuryl, tri-allate and urea.

• (3) That allocation should be made in such a way that a balance is achieved as regards the distribution of the responsibilities and the work between Member States.

• (4) This Regulation should enter into force as soon as possible given that the deadline for the submission of the supplementary dossier for some of the active substances concerned is on 28 February 2018.

• (5) Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.

• (6) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 31 January 2018.

For the Commission

The President

Jean-Claude JUNCKER

ANNEX

The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

• (1) In Part B, the entries corresponding to active substances Aluminium ammonium sulphate, Azoxystrobin, Bupirimate, Carbetamide, Chlormequat, Ethylene, Fenbuconazole, Fluopicolide, Fluquinconazole, Flutriafol, Garlic extract, Metazachlor, Myclobutanil, Paclobutrazol, Pepper, Plant oils/Citronella oil, Propaquizafop, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Tri-allate and Urea are replaced by the following corresponding entries:

• (2) The following Part C is added:

‘ PART C

ALLOCATION OF THE EVALUATION OF ACTIVE SUBSTANCES WHOSE APPROVAL EXPIRES AFTER 31 DECEMBER 2021 AND NOT LATER THAN 31 DECEMBER 2024

Active substance	Rapporteur Member State	Co-rapporteur Member State
1,4-Dimethylnaphthalene	AT	PL
Acequinocyl	DE	NL
Adoxophyes orana GV strain BV-0001	DE	FR
Ametoctradin	DE	NL
Aminopyralid	FI	DK
Amisulbrom	EL	FI
Ascorbic acid	NL	FR
Aureobasidium pullulans (strains DSM 14940 and DSM 14941)	AT	DE
Bacillus firmus I-1582	FR	DK
Bacillus pumilus QST 2808	IT	NL
Benalaxyl-M	PT	IT
Benzovindiflupyr	FR	AT
Bixafen	CZ	BE
Candida oleophila strain O	SI	DE
Chlorantraniliprole	IE	DE
Cyflumetofen	ES	AT
Disodium phosphonate	FR	EL
Emamectin	NL	SI
Esfenvalerate	AT	PT
Eugenol	ES	EL
Fenpyrazamine	LV	LT
Flubendiamide	EL	AT
Flumetralin	HU	EL
Fluopyram	AT	HR
Fluxapyroxad	FR	EL
Geraniol	ES	EL
Halosulfuron methyl	IT	PL
Helicoverpa armigera nucleopolyhedrovirus (HearNPV)	EE	FR
Ipconazole	BE	FR
Isopyrazam	NO	EL
lambda-Cyhalothrin	SE	FR
Maltodextrin	IE	FR
Mandipropamid	AT	PT
Metaflumizone	SE	EL
Metam (incl. -potassium and -sodium)	BE	ES
Metobromuron	FR	NO
Metsulfuron-methyl	DK	SE
Orange oil	FR	CZ
Paecilomyces fumosoroseus strain Fe9901	PL	NL
Penflufen	PL	IE
Penthiopyrad	SE	CZ
Phosphane	ES	DE
Potassium phosphonates (formerly potassium phosphite)	FR	EL
Prosulfuron	FR	SK
Pseudomonas sp. Strain DSMZ 13134	NL	BG
Pyridalyl	NL	BE
Pyriofenone	LV	EL
Pyroxsulam	DK	FI
S-Abscisic acid	NL	DK
Sedaxane	FR	AT
Sodium silver thiosulphate	NL	LV
Spinetoram	HR	ES
Spiromesifen	IT	AT
Spirotetramat	AT	NO
Spodoptera littoralis nucleopolyhedrovirus	EE	FR
Streptomyces lydicus WYEC 108	NL	DE
Tembotrione	AT	FR
Thiencarbazone	FR	EL
Thymol	ES	EL
Trichoderma asperellum (strain T34)	SE	IT
Trichoderma atroviride strain I-1237	IT	SK
Valifenalate (formerly Valiphenal)	HU	SI
Zucchini Yellow Mosaik Virus, weak strain	DK	AT’